Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia: A Double Blind, Randomized Controlled Study

NCT04352569 is registered in ClinicalTrials.gov with Centre hospitalier de Ville-Evrard, France as lead sponsor.

NCT NCT04352569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04352569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia: A Double Blind, Randomized Controlled Study
Lead sponsor
Centre hospitalier de Ville-Evrard, France
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2016
Completion date
March 31, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hallucinations, refractory schizophrenia, schizophrenia